

Learn about common and serious Combipatch side effects, how to manage them, and when to seek medical attention. Updated for 2026.
Combipatch is a transdermal hormone replacement therapy (HRT) patch that delivers Estradiol and Norethindrone Acetate through the skin. Like all hormone therapies, it comes with potential side effects. Most are mild and improve over time, but some require immediate medical attention.
This guide covers what to expect when you start Combipatch, how to manage common side effects, and the warning signs that mean you should call your doctor right away. If you're new to this medication, start with our overview of what Combipatch is and how it works.
The following side effects are reported frequently and usually improve within the first few weeks or months of use:
Redness, irritation, and itching at the patch site are the most common side effects. This happens because the adhesive and medication are in direct contact with your skin.
What to do: Rotate your application site with each new patch. Apply to a clean, dry area on your lower abdomen. Avoid areas with cuts, irritation, or lotions. If irritation persists, talk to your doctor — a different patch brand or formulation may work better.
Headaches are common when starting HRT as your body adjusts to new hormone levels. They usually decrease over time.
What to do: Over-the-counter pain relief (like Acetaminophen) can help. Stay hydrated and maintain consistent sleep. If headaches become severe or frequent, contact your provider.
Breast tenderness is a well-known effect of estrogen and progestin therapy. It's usually mild and temporary.
What to do: Wear a supportive bra. Reduce caffeine intake, which can worsen breast tenderness. If pain is severe or you notice a lump, see your doctor promptly.
Some women experience mild nausea, particularly in the first few weeks. Transdermal delivery generally causes less nausea than oral HRT because the hormones bypass the stomach.
What to do: If nausea persists beyond the first month, talk to your doctor about adjusting your dose or timing.
Hormonal changes can affect digestion and cause bloating, gas, or mild abdominal discomfort.
What to do: Eating smaller meals, staying active, and avoiding carbonated beverages may help. Persistent or severe abdominal pain warrants a doctor's visit.
Irregular bleeding or spotting is common in the first 3 to 6 months of HRT use. The progestin component (Norethindrone Acetate) affects the uterine lining, which can cause unpredictable bleeding patterns initially.
What to do: Track your bleeding patterns. If bleeding continues beyond 6 months, becomes heavy, or occurs after a period of no bleeding, contact your doctor to rule out other causes.
Some women report back pain while using Combipatch. This may or may not be directly related to the medication.
Fluctuating hormone levels can affect mood. Some women feel more emotional, anxious, or irritable when starting HRT.
What to do: Give your body time to adjust. If mood changes are significant or don't improve after a few weeks, discuss them with your provider. Underlying conditions like depression should be evaluated separately.
Mild weight fluctuation (usually a few pounds) can occur due to fluid retention or metabolic changes from hormone therapy.
While rare, Combipatch carries risks of serious side effects. The FDA requires a boxed warning — the most serious type of warning — on all estrogen-progestin HRT products. Call your doctor or seek emergency care if you experience any of the following:
These could indicate deep vein thrombosis (DVT) or pulmonary embolism (PE), both of which are medical emergencies.
Report any new breast lumps, nipple discharge, or changes in breast shape to your doctor. Long-term use of estrogen-progestin therapy is associated with a small increased risk of breast cancer.
Sudden vision loss, blurred vision, or double vision could indicate retinal vascular thrombosis and requires immediate evaluation.
Combipatch's boxed warning states that estrogen-progestin therapy should not be used to prevent heart disease or dementia. The Women's Health Initiative (WHI) study found increased risks of DVT, pulmonary embolism, stroke, heart attack, invasive breast cancer, and probable dementia in postmenopausal women using combination HRT.
This doesn't mean Combipatch is unsafe for everyone. It means the medication should be used at the lowest effective dose for the shortest time needed to treat your symptoms. Your doctor will weigh the benefits against these risks based on your individual health profile. To understand more about how Combipatch works in the body, see our guide on Combipatch's mechanism of action.
Combipatch is not for everyone. You should not use it if you have:
If you can't use Combipatch, explore alternative treatments with your doctor.
Call your doctor's office for: persistent headaches, ongoing nausea, breast tenderness that doesn't improve, breakthrough bleeding beyond 6 months, mood changes, or skin reactions that won't resolve with site rotation.
Go to the emergency room or call 911 for: signs of blood clots, stroke, heart attack, severe allergic reaction, sudden vision loss, or signs of liver problems.
Most Combipatch side effects are mild and manageable. Skin irritation, headaches, and breast tenderness are the most common and usually improve with time. Serious side effects are rare but important to recognize. Work closely with your doctor, attend your follow-up appointments, and don't hesitate to reach out if something doesn't feel right.
If you're having trouble finding Combipatch at your pharmacy, MedFinder can help you check pharmacy stock without making a single phone call.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.